Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
RingCentral issued a press release on October 22, 2026 disclosing financial results for the third quarter ended September 30, 2026. The filing includes detailed quarterly revenue ($676 million, up 5.9% YoY), operating income, EPS, cash flow metrics, and raised full-year 2026 guidance for revenue, margins, and free cash flow. This is a standard quarterly earnings release material to investors assessing the company's financial performance and outlook.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
Tara Poseley was appointed as a member of lululemon's Board of Directors, effective October 19, 2026, expanding the board from twelve to thirteen members. Her appointment, tied to a cooperation agreement with founder Chip Wilson, reflects her substantial retail and product expertise and prior service as the company's Chief Product Officer.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
This is a clear earnings release for Q3 2026 ended September 30, 2026. The press release discloses quarterly financial results including revenue of $296 million (19% YoY growth), GAAP operating income of $57 million, and net income of $46 million, along with full-year 2026 guidance. The filing is structured as Item 2.02 with the press release attached as Exhibit 99.1, which is the standard format for earnings disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
Item 2.02 discloses Insteel Industries' fourth quarter and fiscal year 2026 financial results via a news release furnished as Exhibit 99.1. The release presents consolidated statements of operations, balance sheets, and cash flows for the periods ended October 3, 2026, along with detailed commentary on net earnings ($7.7M for Q4, $29.5M for FY2026), net sales ($209.3M for Q4, $739.5M for FY2026), and gross margins. This is a standard earnings release disclosure material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-10-22
Item 2.02
ConnectOne Bancorp issued a press release on October 22, 2026, disclosing third quarter 2026 financial results, including net income of $29.9 million, diluted EPS of $0.59, and key operating metrics. The filing is structured as Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for earnings releases. While the release also discusses a balance sheet restructuring and loan sale, the primary disclosure is the quarterly earnings announcement.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
Lattice Semiconductor appointed John McCool and Raejeanne Skillern to its Board of Directors effective October 21, 2026, expanding the Board from 8 to 10 directors. Both appointees bring substantial experience in semiconductors, cloud infrastructure, and technology leadership, and will receive annual cash retainers of $80,000 and RSU awards valued at $220,000.
View raw filing on EDGAR →
8-K
Governance Other
confidence 72%
filed 2026-10-22
Item 8.01
The filing discloses Dean Zikria's first 30-day assessment as interim CEO, outlining strategic priorities for clinical development, commercialization, and evaluation of strategic opportunities for Velocity Bioworks. While this is primarily a governance matter (leadership communication and strategic direction), it does not fit neatly into the specific governance categories (exec_appointment, exec_departure, exec_compensation, or shareholder_vote_results). The disclosure is material because it signals a significant strategic shift under new interim leadership, including potential M&A activity for Velocity, which would affect investor assessment of the company's direction and value creation prospects.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
ECB Bancorp issued a press release on October 22, 2026 announcing third quarter 2026 financial results, including net income of $3.4 million ($0.40 per diluted share), balance sheet metrics, and detailed financial highlights. This is a standard quarterly earnings disclosure filed under Item 2.02 with the press release attached as Exhibit 99.1, which is material to investors assessing the registrant's financial performance and condition.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-10-22
Item 1.01
Climb Global Solutions entered into a Sale and Purchase Agreement on October 21, 2026, to acquire 100% of NeoVAD, a France-based IT distributor, for approximately €16.0 million (~$18.0 million), representing a strategic expansion of Climb's European platform with expected accretion to earnings and adjusted EBITDA.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-10-22
Item 8.01
The Board of Directors declared a quarterly cash dividend of $0.33 per common share payable November 17, 2026. This is a routine but material capital allocation decision that affects shareholder value and is customarily disclosed under Item 8.01 for dividend declarations.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-10-22
Item 5.02
William Christopher McDougall was appointed by the Board on October 17, 2026, to the positions of Chief Financial Officer, Treasurer, and Assistant Secretary effective immediately, with designation as principal financial officer. This is a clear executive appointment to a material C-suite role. While the disclosure also mentions Bryce D. Klug's continued service as principal accounting officer, the principal disclosed action centers on McDougall's appointment to CFO and related officer positions.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
This is a clear earnings release disclosing quarterly and nine-month financial results for Farmers and Merchants Bancshares, Inc. The press release reports net income of $5.7 million ($1.76 per share) for the nine months ended September 30, 2026, compared to $4.1 million ($1.28 per share) for the same period in 2025, along with detailed consolidated financial statements and performance metrics. The filing is furnished under Item 2.02 (Results of Operation and Financial Condition), which is the standard Item for earnings releases.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-10-22
Item 5.02
The filing discloses the appointment of Kelsey Cassinelli as Executive Vice President and Chief Financial Officer effective January 1, 2027, following Richard Belstock's retirement from that position. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a new CFO with specified compensation ($300,000 annual base salary) and eligibility for incentive and equity programs. The appointment of a CFO is material to investors' assessment of the company's financial leadership and governance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
Boyd Gaming issued a press release on October 22, 2026, announcing third-quarter 2026 financial results, including revenues of $990.5 million, net income of $124.9 million ($1.71 per share), and Adjusted EBITDAR of $319.6 million. The filing explicitly states the press release is furnished as Exhibit 99.1 and incorporated by reference under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. This is a material quarterly earnings disclosure affecting investor assessment of the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-10-22
Item 2.02
Marten Transport disclosed third quarter 2026 financial results via press release, reporting net income of $2.9 million (4 cents per diluted share) for Q3 2026 compared to $2.2 million (3 cents per diluted share) for Q3 2025, along with nine-month results and detailed segment performance data.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-10-22
Item 2.02
Dorchester Minerals announced its third quarter 2026 cash distribution of $0.882297 per common unit, payable on November 12, 2026. As a master limited partnership, this routine distribution to unitholders is a core business activity and material to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
The filing discloses Orchid Island Capital's third quarter 2026 financial results via a press release attached as Exhibit 99.1. The disclosure includes net loss of $178.9 million ($0.90 per share), net interest income, total expenses, net realized and unrealized losses on RMBS and derivatives, book value per share of $6.02, and a total return of (12.47%). This is a standard quarterly earnings release under Item 2.02, material to investors assessing the REIT's operational and financial performance.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-10-22
EX-99.1
This press release announces a positive interim milestone in Vicore's Phase 2b ASPIRE clinical trial: the independent Data Monitoring Committee recommended the trial continue without modification following a pre-planned futility analysis, with no safety concerns identified. The trial remains on track for mid-2027 topline results. This is a material operational/clinical development event for a clinical-stage biopharmaceutical company, as it demonstrates progress toward a key regulatory milestone and affects investor assessment of the company's lead program viability and cash runway. The disclosure does not fit discrete event categories like earnings_release, ma_activity, or exec changes, but represents a material clinical/operational milestone that would affect a reasonable investor's view of the company's prospects.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
The filing discloses Investar Holding Corporation's third quarter 2026 financial results via a press release dated October 22, 2026, reporting net income of $11.1 million ($0.74 per diluted share), net interest margin of 3.73%, and other key financial metrics. This is a standard quarterly earnings release filed under Item 2.02 with exhibits 99.1 and 99.2 containing the earnings release and investor presentation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-10-22
Item 5.07
Shareholders approved five proposals at a special meeting on October 16, 2026, including an asset purchase issuance, a name change to Parabolic Technologies, Inc., equity plan amendments, a 1-for-10 reverse stock split, and an adjournment proposal, all passing by majority vote.
View raw filing on EDGAR →
8-K
Governance Other
confidence 80%
filed 2026-10-22
Item 3.03
Following shareholder approval on October 16, 2026, Banzai International, Inc. effected a 1-for-10 reverse stock split of its Class A and Class B Common Stock via amendment to its Certificate of Incorporation filed with Delaware, materially affecting share count, CUSIP numbers, and trading mechanics to maintain Nasdaq compliance.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-10-22
Item 1.01
On October 16, 2026, the Company entered into multiple debt agreements with its COO and CEO, including subordinated secured promissory notes, revolving lines of credit, and amended loan agreements totaling approximately $347,000+ in principal and accrued obligations, with interest rates ranging from 18–29.99% per annum.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-10-22
Item 2.02
Midland States Bancorp issued a press release on October 22, 2026 announcing third-quarter 2026 financial results, including net income of $20.6 million ($0.95 per diluted share), return on average assets of 1.35%, and net interest margin of 4.03%, along with comprehensive financial highlights and performance metrics.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-10-22
Item 1.01
Edible Garden AG entered into a Produce Supply Agreement with Caney Fork Farms, LLC on October 16, 2026, to purchase fresh produce for its core herb business with fixed pricing through January 31, 2027, and a committed volume schedule through October 15, 2028. This is a material operational contract governing a key input supply chain for the company's core business, but does not constitute a merger, acquisition, disposition, or other M&A activity. The agreement is material to investors as it secures supply continuity for the registrant's herb business operations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 94%
filed 2026-10-22
Item 2.02
Cosmos Health disclosed preliminary Q4 2026 U.S. revenue of approximately $15 million with gross profit of $10.5 million, nine-month 2026 revenue of $54.3 million (up 19%), and full-year 2026 revenue guidance exceeding $90 million (up ~38%), via press release and CEO letter.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-10-22
Item 2.02
The Company issued a press release on October 22, 2026 announcing financial results for the three and nine months ended September 30, 2026, including net sales of $244 million (34% increase), net income of $35 million, and raised full-year 2026 guidance for net sales to $810–$820 million and Adjusted EBITDA to $170–$175 million. This is a standard quarterly earnings release disclosure under Item 2.02, furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-10-22
Item 2.02
Customers Bancorp issued a press release on October 22, 2026 announcing unaudited financial results for Q3 2026, including net income of $78.4 million ($2.25 per diluted share), deposit and loan growth metrics, net interest income of $208 million, efficiency ratio of 47.2%, and updated full-year 2026 guidance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-10-22
The filing discloses the resignation of Prabodh Kumar Kantilal H Sheth from Greenpro Capital Corp.'s Board of Directors, effective October 31, 2026. Item 5.02 explicitly covers departures of directors, and the prose confirms this is a resignation with no disagreement cited. Board departures are material to investors assessing governance and leadership continuity.
View raw filing on EDGAR →
6-K
Operational Other
confidence 80%
filed 2026-10-22
EX-99.1
Gunnison Copper announced commencement of trading on NYSE American under ticker 'GUNN' effective October 26, 2026, via a Level II ADR program, representing a material strategic milestone that expands U.S. investor access and enhances the company's visibility in U.S. capital markets as an American copper producer.
View raw filing on EDGAR →
6-K
M&A activity
confidence 85%
filed 2026-10-22
EX-99.1
Fusion Fuel has entered into a Share Exchange Agreement with its majority-owned subsidiary QIND to restructure QIND's remaining purchase price obligations for its 51% ownership interest in Al Shola Gas. The transaction involves issuance of 500,000 Fusion Fuel Class A Ordinary Shares valued at $2.0 million in exchange for QIND equity, restructuring $2.0 million of QIND's $10.0 million total purchase price obligation, and eliminating legacy financing commitments. This constitutes a material restructuring of acquisition-related obligations and equity issuance that would affect investor assessment of the registrant's capital structure and subsidiary obligations.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-10-22
The filing discloses a material restructuring of QIND's purchase price obligations for its 51% ownership in Al Shola Gas through an Amendment to the Share Purchase Agreement and a concurrent Share Exchange Agreement with majority shareholder Fusion Fuel. While not a traditional M&A transaction, this restructuring materially modifies the terms of an existing acquisition (originally dated March 27, 2024) and involves a significant share exchange ($2.0 million in Fusion Fuel shares to satisfy purchase price obligations), removal of financing commitments, introduction of quarterly dividends, and grant of a call option. The forward-looking statements emphasize risks to closing conditions and QIND's ability to satisfy remaining $6.98 million in obligations, indicating materiality to investors assessing the company's financial position and ownership structure.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-10-22
MIRA Pharmaceuticals disclosed positive preclinical study results for MIRA-55 in a chronic inflammatory pain model, demonstrating efficacy comparable to celecoxib without tolerance. The filing is disclosed under Item 7.01 (Regulation FD Disclosure) and represents a material operational/clinical development milestone supporting advancement toward an IND submission in Q1 2027. While not a traditional earnings release or financial event, the positive preclinical data is material to investors' assessment of the company's drug development pipeline and clinical prospects.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-10-22
EX-99.1
This exhibit is a press release announcing unaudited financial results for the six months ended June 30, 2026. The document presents consolidated balance sheets, statements of income, and detailed commentary on revenue, expenses, and financial performance for the interim period. While the company reported a net loss of S$3.0 million (approximately $2.3 million) and flat revenue of S$2.5 million, the disclosure of interim financial results in press-release format constitutes an earnings release. The materiality is supported by the inclusion of detailed financial statements and the company's disclosure of significant subsequent events (including a proposed acquisition and new loan facility), which would affect a reasonable investor's assessment of the registrant's financial condition.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-10-22
The Board approved an amendment to the Company's share repurchase program on October 19, 2026, increasing the aggregate authorization from $15.0 million to $35.0 million and extending the program through July 4, 2027. Share repurchase programs constitute a form of capital return to shareholders and fall within the dividend_distribution category. The $20 million increase in authorization and extension of the program term represent material capital allocation decisions that would affect investor assessment of the company's capital strategy.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-10-22
Item 3.02
The filing discloses the completion of an acquisition of technology, designs, and know-how for automated optical inspection machines from Jun Long Machine Industrial Co., Ltd., which closed on October 19, 2026. Item 3.02 references unregistered equity issuance in connection with the transaction, and the Asset Purchase Agreement is filed as Exhibit 10.1. This is a material acquisition of specified technology assets that establishes a new business line (semiconductor packaging inspection equipment) with projected monthly sales of $1.5–$2.25 million.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-10-22
Item 2.02
Item 2.02 discloses preliminary third-quarter 2026 financial results for 22nd Century Group issued on October 22, 2026. The filing includes a preliminary earnings release (Exhibit 99.1) reporting revenue of $4.8 million (66% growth), gross profit of $0.4 million, and net loss of $2.6 million. This is a standard quarterly earnings disclosure material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-10-22
EX-99.1
This is a press release announcing Click Holdings' record full-year financial results for the fiscal year ended June 30, 2026. The disclosure reports revenue of HK$135.2 million (up 61.9% YoY), gross profit of HK$21.6 million (up 68.9%), and net income of HK$14.59 million, representing a significant swing from prior-year losses. The filing explicitly states it is "concurrent with the filing of its Annual Report on Form 20-F," confirming this is the earnings announcement for the full fiscal year. Material improvements across all three segments (nursing, professional, logistics) and the return to profitability make this material to investors.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-10-22
The filing discloses drill results from the 2026 reverse circulation program at the Lapon Canyon Gold Project, including significant gold intercepts (2.07 g/t Au over 47.3 metres). This is an operational/exploration milestone for a mining company with an earn-in agreement and royalty interest. While material to investors evaluating the company's project portfolio and exploration progress, it does not fit the specific event types (earnings release, M&A, impairment, etc.) and is best classified as an operational disclosure of exploration results under Item 7.01 Regulation FD Disclosure.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-10-22
The 6-K discloses the Board's adoption on October 16, 2026 of the Rantizo 2026-2027 Equity Incentive Plan, which reserves 6,000,000 Class A ordinary shares for issuance as stock options, restricted stock, restricted stock units, and performance awards to directors, officers, employees, and consultants. This is a compensatory arrangement affecting named executives and broad employee groups, falling squarely within exec_compensation. The plan's material scope (6 million shares reserved) and ten-year term make it material to investor assessment of capital structure and executive incentives.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-10-22
The Tribunal of Milan issued an interim order on October 19, 2026, suspending execution of the Board appointment resolution from the June 29, 2026 shareholders' meeting and reinstating the prior Board of Directors in a prorogatio regime. This is a material governance event involving judicial intervention in corporate leadership and board composition, though it is an interim measure pending appeal rather than a final determination. The disclosure affects investor assessment of corporate control and governance structure.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-10-22
EX-99.1
This press release announces two technology milestones achieved by Quantum X Labs Inc., a company in which Gix Internet holds a ~13% minority stake: (1) deployment of QXL's quantum error-correction decoder on NVIDIA CUDA-Q with demonstrated performance improvements (12–13% fewer logical errors), and (2) experimental validation of LayerQake quantum cybersecurity technology on IBM quantum processors with significant error reduction (15- to 21-fold). While Gix does not control QXL and has not independently verified results, the announcement of material technological progress by a significant portfolio company represents an operational/strategic milestone that could affect investor assessment of Gix's strategic positioning and future prospects, particularly given the company's stated strategy to extend its management architecture to autonomous systems and complex environments.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-10-22
EX-99.1
This exhibit is an amendment to a Notice and Proxy Statement that updates and finalizes an IPT (Interested Person Transaction) General Mandate for shareholder approval. The amendment corrects page 90 and substitutes a final form of the IPT General Mandate (Annex B) for the draft version previously disclosed. The IPT General Mandate is a governance matter requiring shareholder approval under SGX-ST Listing Manual Chapter 9, governing the company's ordinary-course transactions with 20 named interested persons across multiple categories (procurement, goods purchase/sale, leasing, and security provision). This is material to investors as it establishes the framework for related-party transactions and requires shareholder voting approval.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-22
Alpha Modus entered into a Securities Purchase Agreement on October 21, 2026, to sell 6,304,348 shares of Class A common stock at $1.15 per share in a registered direct offering, generating approximately $7.25 million in gross proceeds. The company also agreed to issue placement agent warrants representing 7.0% dilution. This is a classic registered direct offering—a dilutive equity issuance to raise capital, with proceeds earmarked for debt repayment and working capital.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-10-22
The filing discloses a 1-for-10 reverse stock split of Azitra's common stock, effectuated via amendment to the certificate of incorporation filed on October 22, 2026 and becoming effective October 26, 2026. This is a governance event involving modification of the company's capital structure and security holder rights (Item 3.03 and 5.03). While reverse splits are routine corporate actions, this one is material to investors as it affects share count, trading price, and the company's market presentation—particularly relevant given Azitra's status as an emerging growth company trading on NYSE American.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-10-22
The filing discloses Item 3.01 notice of delisting risk: Nasdaq determined the Company's warrants failed to maintain the required $1 million aggregate market value under Listing Rule 5452(b)(C), and while an extension to February 23, 2027 was granted, failure to regain compliance by that date will result in delisting notification. This is a material disclosure of continued listing jeopardy.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-10-22
The filing discloses amendments to the Company's Series A and Series B Preferred Stock certificates of designation and PIPE Warrants, establishing floor prices ($0.16 for Series A, $0.266 for Series B and warrants) that restrict anti-dilution adjustments and repricing. These amendments modify the rights and economic terms of preferred securities and warrants, which are governance-level modifications to the capital structure. While the amendments address Nasdaq listing requirements and accounting considerations, they are fundamentally structural changes to security terms that would materially affect investor valuations and dilution expectations.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-10-22
The filing discloses results of a Special Meeting of Stockholders held on October 22, 2026, where stockholders voted on a proposal to amend the Certificate of Incorporation to increase authorized shares from 170 million to 320 million total shares and from 150 million to 300 million common shares. The proposal was approved with 37,675,355 votes in favor, 10,125,739 against, and 283,147 abstentions. This is a classic Item 5.07 shareholder vote result disclosure and is material as it reflects a significant capital structure change approved by shareholders.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-10-22
The filing discloses the dismissal of Forvis Mazars, LLP as the Company's independent registered public accounting firm, effective following the filing of the Q3 2026 10-Q. The disclosure explicitly states the Audit Committee and Board approved this dismissal on October 16, 2026. While the auditor's reports contained no adverse opinions or disclaimers, they included an explanatory paragraph regarding substantial doubt about going concern, and the Company identified multiple material weaknesses in internal controls. This is a clear auditor change event under Item 4.01.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-22
The filing discloses an unregistered sale of 15,000 shares of Series C Convertible Preferred Stock to accredited investors for $15.0 million aggregate proceeds on October 21, 2026, under Item 3.02. The Series C Preferred Stock is convertible into common stock at an initial conversion price of $0.3519 per share, with significant dilutive features including 20% annual dividends payable in common stock, a 300% liquidation preference, and director designation rights. This is a classic private placement of convertible securities that will substantially dilute existing common shareholders upon conversion.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 45%
filed 2026-10-22
The filing discloses that the Company's largest stockholder, Asamitsu Kosugi, intends to surrender 97,413,140 shares (approximately 20% of outstanding common stock) for no consideration. While this is technically a share cancellation rather than a new issuance, it materially affects the capital structure and proportionate ownership interests of remaining shareholders. The event is material to investors as it represents a significant reduction in share count and dilution of ownership stakes. However, the classification is uncertain because this is a voluntary surrender/cancellation by a major shareholder rather than a traditional dilutive issuance by the company itself, and no specific 8-K item type perfectly captures this shareholder-initiated capital reduction.
View raw filing on EDGAR →